Article
OTAL media kit
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
KALA Bio completes enrollment of CHASE clinical trial
3 Things You Should Know About Interventional Glaucoma Comanagement
LIGHTHOUSE study of ATSN-201 expanded to continuous phase 1/2/3 trial following FDA feedback
Patient-Centered Treatment Strategies in the Management of nAMD and DME
Belite Bio completes enrollment in global phase 3 PHOENIX trial for geographic atrophy
Study data link cannabis use to lower risk of proliferative vitreoretinopathy after retinal detachment repair